Senzime announced that Eva Walde is appointed new acting Board Member to be elected a at the next shareholders meeting. Eva has 20 years of experience in leading roles in companies such as Johnson & Johnson, Pfizer and Thermo Fisher. Eva is currently a Board member of Sedana Medical AB (publ.). The appointment of a new Board member has taken place through an external recruitment process on behalf of the Nomination Committee of Senzime, consisting of Philip Siberg, Adam Dahlberg, Lennart Kalén and Sorin J. Brull.